I-131 RADIOIODINE THERAPY FOR HYPERTHYROIDISM IN PATIENTS WITH GRAVES-DISEASE, UNINODULAR GOITER AND MULTINODULAR GOITER

被引：0
|
作者：
DANACI, M
FEEK, CM
NOTGHI, A
MERRICK, MV
PADFIELD, PL
EDWARDS, CRW
机构：
[1] WESTERN GEN HOSP,DEPT MED,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
[2] WESTERN GEN HOSP,DEPT NUCL MED,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
来源：
NEW ZEALAND MEDICAL JOURNAL | 1988年 / 101卷 / 858期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：784 / 786
页数：3
相关论文
共 50 条
  • [41] COMPARISON OF I-131 AND I125 THERAPY IN GRAVES-DISEASE
    SHLOSSBERG, AH
    ABBOTT, EC
    MARTIN, R
    HICKEY, J
    NEW ZEALAND MEDICAL JOURNAL, 1977, 86 (597) : 352 - 352
  • [42] RESULTS OF TREATMENT OF GRAVES-DISEASE BY I-131
    RIVIERE, J
    ROGER, P
    NOGUE, F
    EMPERAIRE, JC
    LATAPIE, JL
    REBOUL, J
    BLANQUET, P
    ANNALES D ENDOCRINOLOGIE, 1974, 35 (01) : 38 - 39
  • [43] Radioiodine Therapy (I-131) for Hyperthyroidism: Our experience
    Gouveia, P.
    Teixeira, R.
    Brito, R.
    Amorim, I.
    Castro, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S421 - S421
  • [44] OPTIMAL I-131 DOSE IN GRAVES-DISEASE
    SCHOBER, B
    COHEN, P
    LENTLE, B
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (12) : 2359 - 2359
  • [45] Measurement of serum thyroglobulin levels in patients with toxic adenoma and multinodular tosic goiter before and after the therapy with I-131
    Bonefacic, B.
    Grbac-Ivankovic, S.
    Petretic-Majnaric, S.
    Smokvina, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S444 - S444
  • [46] THE GAMMA-DELTA T-CELL REPERTOIRE IN GRAVES-DISEASE AND MULTINODULAR GOITER
    MCINTOSH, RS
    TANDON, N
    PICKERILL, AP
    DAVIES, R
    WEETMAN, AP
    BARNETT, D
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1993, 94 (03) : 473 - 477
  • [47] Thyroid Hemiagenesis with Graves' Disease, Graves' Ophthalmopathy and Multinodular Goiter
    Cakir, Mehtap
    Gonen, Sait
    Dikbas, Oguz
    Ozturk, Banu
    INTERNAL MEDICINE, 2009, 48 (12) : 1047 - 1049
  • [48] THYROTROPIN RECEPTOR ANTIBODY ACTIVITIES SIGNIFICANTLY CORRELATE WITH THE OUTCOME OF RADIOIODINE (I-131) THERAPY FOR HYPERTHYROID GRAVES-DISEASE
    KAISE, K
    KAISE, N
    YOSHIDA, K
    FUKAZAWA, H
    MORI, K
    YAMAMOTO, M
    SAKURADA, T
    SAITO, S
    YOSHINAGA, K
    ENDOCRINOLOGIA JAPONICA, 1991, 38 (04): : 429 - 433
  • [49] COMPENSATED LOW-DOSE I-131 THERAPY OF GRAVES-DISEASE
    ROUDEBUSH, CP
    HOYE, KE
    DEGROOT, LJ
    ANNALS OF INTERNAL MEDICINE, 1977, 87 (04) : 441 - 443
  • [50] Thyrotropin receptor antibodies and Graves' disease, a side-effect of I-131 treatment in patients with nontoxic goiter
    Nygaard, B
    Knudsen, JH
    Hegedus, L
    Scient, AVC
    Hansen, JEM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) : 2926 - 2930
12345